Journals / Van Tıp Dergisi / 2014 / Cilt: 21 - Sayı: 3

Evaluation of moderate and severe ovarian hyperstimulation syndrome patients

Orta ve ağır ovaryen hiperstimulasyon sendromlu hastaların değerlendirilmesi

Pages
164–169
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Thus, identification of high risk patients, selection of appropriate strategies and protocols in the first stage will prevent this life- threatening complication.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Evaluation of moderate and severe ovarian hyperstimulation syndrome patients.
📊
Key Findings & Data:Material and Method: In April 2006- February 2012, moderate and severe ovarian hyperstimulation syndrome patients’ clinic datas were analyzed retrospectively.
💡
Conclusion & Impact:Thus, identification of high risk patients, selection of appropriate strategies and protocols in the first stage will prevent this life- threatening complication.
🔬Design:Research Article
📍Scope:2006 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: Evaluation of moderate and severe ovarian hyperstimulation syndrome patients. Material and Method: In April 2006- February 2012, moderate and severe ovarian hyperstimulation syndrome patients’ clinic datas were analyzed retrospectively. Result: 49 patients were studied. 18 patients were early, 31 patients were late ovarian hyperstimulation syndrome. 4 clinical pregnancy were seen in early ovarian hyperstimulation group; in the other group 13 clinical pregnancy were seen. Complication rate of the ovarian hyperstimulation syndrome was 2.04%. Discussion: Ovarian hyperstimulation syndrome is an iatrogenic complication. Thus, identification of high risk patients, selection of appropriate strategies and protocols in the first stage will prevent this life- threatening complication.

Özet

Amaç: Orta ve ağır ovaryen hiperstimulasyon sendromlu hastaları değerlendirilmek. Yöntem: Nisan 2006- Şubat 2012 tarihleri arasında orta ve ağır ovaryen hiperstimulasyon sendromu sebebiyle kliniğimizde yatan hastaların kayıtları retrospektif olarak incelendi. Bulgular: 49 ovaryen hiperstimulasyon sendromu hastası incelendi. 18 hastada erken, 31 hastada geç ovaryen hiperstimulasyon sendromu görüldü. Erken ovaryen hiperstimulasyon sendromu grubunda 4 klinik gebelik varken; geç ovaryen hiperstimulasyon grubunda 13 klinik gebelik meydana geldi. Ovaryen hiperstimulasyon sendromu sonrası komplikasyon oranı %2.04 olarak saptandı. Sonuç: Ovaryen hiperstimulasyon sendromu iatrojenik bir komplikasyondur. Bu sebeple yüksek riskli hastaların tanımlanması, uygun stratejilerin ve protokol seçiminin ilk aşamada belirlenmesi, hayatı tehdit eden böyle bir komplikasyonun ortaya çıkmasını büyük ölçüde engelleyecektir.

🔖

Cite This Article

ÇETİN, O., YILDIRIM, Ö., VERİT, F. F., ZEBİTAY, A. G., YÜCEL, O. (2014). Evaluation of moderate and severe ovarian hyperstimulation syndrome patients. Van Tıp Dergisi, Cilt: 21 - Sayı: 3, 164–169. https://ajindex.com/articles/334115

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Sansone P, Aurilio C, Pace MC, Esposito R, Passavanti MB, Pota V, et al. Intensive care treatment of ovarian hyperstimulation syndrome. Ann N Y Acad Sci 2011; 1221:109-118
  2. Rizk B. Symposium: Update on prediction and management of OHSS, Genetics of ovarian hyperstimulation syndrome. Reprod Biomed Online 2009; 19(1):14–27
  3. Lee KH, Kim SH, Jee BC, Kim YJ, Suh CS, Kim KC, et al. Comparison of clinical characteristics between early and late patterns in hospitalized patients with ovarian hyperstimulation syndrome. Fertil Steril 2010; 93(7):2274-2280
  4. Humaidan P, Quartarolo J, Papanikolaou EG. Preventing ovarian hyperstimulation syndrome: guidance for the clinician. Fertil Steril 2010; 94(2):389-400
  5. Chen CD, Chen SU, Yang YS. Prevention and management of ovarian hyperstimulation syndrome Best Pract Res Clin Obstet Gynaecol 2012; 26(6):817-827
  6. Lee TH, Liu CH, Huang CC, Wu YL, Shih YT, Ho HN, et al. Serum anti-mullerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles. Hum Reprod 2008; 23(1):160-167
  7. Courbiere B, Oborski V, Braunstein D, Desparoir A, Noizet A, Gamerre M. Obstetric outcome of women with in vitro fertilization pregnancies hospitalized for ovarian hyperstimulation syndrome: a case-control study. Fertil Steril 2011; 95(5):1629-1632
  8. European Society of Human Reproduction (ESHRE). Special Interest Group (SIG) guidelines on ovarian hyperstimulation syndrome (OHSS). Available from: http: //www. eshre. com/emc; 2005
  9. Practice Committee of American Society for Reproductive Medicine (ASRM). Ovarian hyperstimulation syndrome. Fertil Steril 2008; 90(5 Suppl):188-193
  10. Delvigne A, Demoulin A, Smitz J, Donnez J, Koninckx P, Dhont M, et al. The ovarian hyperstimulation syndrome in in-vitro fertilization: a Belgian multicentric study. I. Clinical and biological features. Hum Reprod 1993; 8(9):1353-1360
  11. Enskog A, Henriksson M, Unander M, Nilsson L, Brännström M. Prospective study of the clinical and laboratory parameters of patients in whom ovarian hyperstimulation syndrome developed during controlled ovarian hyperstimulation for in vitro fertilization. Fertil Steril 1999; 71(5):808-814
  12. Papanikolaou EG, Tournaye H, Verpoest W, Camus M, Vernaeve V, Van Steirteghem A, et al. Early and late ovarian hyperstimulation syndrome: early pregnancy outcome and profile. Hum Reprod 2005; 20(3):636-641
  13. Bodri D, Guillén JJ, Polo A, Trullenque M, Esteve C, Coll